Evaluation of respiratory syncytial virus vaccines in infants and pregnant women

Summary

Project ID: 2024-048/2025 0950 189 000

Project title: Evaluation of respiratory syncytial virus vaccines in infants and pregnant women

Type of response: Research report or technical brief

Knowledge User: Office of the CMOH; MOH

ICES Scientist: Maria Koh

Summary: Ontario introduced in the fall of 2024 a new immunization program, Nirsevimab (NSVB), for the prevention of RSV infection in infants. Unlike the previous program which targeted only high-risk infants, this monoclonal is offered to all infants in the first year of life. We will investigate the uptake of nirsevimab and sociodemographic factors associated with the uptake.

Status: In progress